T1	Outcomes 264 354	changes in transcutaneous PCO2 (tcPCO2), subjective anxiety, heart rate and blood pressure
T2	Outcomes 524 570	fall in tcPCO2 and the cardiovascular response
T3	Outcomes 659 665	tcPCO2
T4	Outcomes 752 774	acute hyperventilation
T5	Outcomes 846 860	fall in tcPCO2
T6	Outcomes 902 948	occurrence of anxiety-related somatic symptoms
